U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 21-27, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 21-27, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 01/23/2024
Location: Virtual
Subject: FDA - Duke Margolis Prevention of Preterm Birth Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 01/25/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Sarah Frey (Frey Farms);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 01/23/2024
Location: Virtual
Subject: Potential Bilateral Memorandum of Understanding
FDA Participant/Group: JESSICA STEWART, JOHN WEINER, ANNA FERUS, JOSEPH RIERAS, AZADA HAFIZ, KRISTAN CALLAHAN
Non FDA Participant/Group: Christianah Mojisola Adeyeye, Ololade Onaolapo (National Agency for Food and Drug Administration and Control (NAFDAC) of Nigeria);

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 01/23/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Cynthia Klein, Maggie Ritsick, Roslyn Brock, Sarah Perez (Abt Associates);

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/24/2024
Location: Silicon Valley, CA
Subject: Precision Medicine World Conference 2024; Panel Chair: Accelerated Approval for Small Populations Biomarkers and Endpoints
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare, academia, and research stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 01/25/2024
Location: Virtual
Subject: Import Strategy
FDA Participant/Group: JOHN HASSENPLUG; JASON SADLER; LAUREN ROBIN;
Non FDA Participant/Group: Farida Mohamedshah, Lory Reveil (National Confectioners Association); Kailee Tkacz Buller (Institute of Shortening and Edible Oils); Analisa Puzzanghero (National Association of Chemical Distributors); Roberta Wagner (International Dairy Foods Association); Allison Cooke (Corn Refiners Association); Emily Moyer (International Fresh Produce Association); Donna Garren (American Frozen Food Institute); Laura Shumow (American Spice Trade Association);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top